PIM Kinases Are a Potential Prognostic Biomarker and Therapeutic Target in Neuroblastoma.
Brunen, Diede
PIM Kinases Are a Potential Prognostic Biomarker and Therapeutic Target in Neuroblastoma. [electronic resource] - Molecular cancer therapeutics 04 2018 - 849-857 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1538-8514
10.1158/1535-7163.MCT-17-0868 doi
Animals
Apoptosis
Biomarkers, Tumor
Biphenyl Compounds--pharmacology
CRISPR-Cas Systems
Cell Proliferation
Female
Follow-Up Studies
Humans
Infant
Male
Mice
Mice, Nude
Neoplasm Recurrence, Local--drug therapy
Neuroblastoma--drug therapy
Neurofibromin 1--genetics
Prognosis
Protein Kinase Inhibitors--pharmacology
Proto-Oncogene Proteins c-pim-1--antagonists & inhibitors
Survival Rate
Thiazolidines--pharmacology
Tumor Cells, Cultured
Xenograft Model Antitumor Assays
PIM Kinases Are a Potential Prognostic Biomarker and Therapeutic Target in Neuroblastoma. [electronic resource] - Molecular cancer therapeutics 04 2018 - 849-857 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1538-8514
10.1158/1535-7163.MCT-17-0868 doi
Animals
Apoptosis
Biomarkers, Tumor
Biphenyl Compounds--pharmacology
CRISPR-Cas Systems
Cell Proliferation
Female
Follow-Up Studies
Humans
Infant
Male
Mice
Mice, Nude
Neoplasm Recurrence, Local--drug therapy
Neuroblastoma--drug therapy
Neurofibromin 1--genetics
Prognosis
Protein Kinase Inhibitors--pharmacology
Proto-Oncogene Proteins c-pim-1--antagonists & inhibitors
Survival Rate
Thiazolidines--pharmacology
Tumor Cells, Cultured
Xenograft Model Antitumor Assays